A detailed history of Nbc Securities, Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, Nbc Securities, Inc. holds 107 shares of BNTX stock, worth $10,670. This represents 0.0% of its overall portfolio holdings.

Number of Shares
107
Previous 100 7.0%
Holding current value
$10,670
Previous $8,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$78.36 - $124.66 $548 - $872
7 Added 7.0%
107 $12,000
Q1 2024

Apr 05, 2024

BUY
$88.96 - $112.35 $4,625 - $5,842
52 Added 108.33%
100 $9,000
Q4 2023

Feb 07, 2024

BUY
$90.91 - $112.75 $3,000 - $3,720
33 Added 220.0%
48 $5,000
Q3 2023

Nov 03, 2023

BUY
$98.5 - $125.08 $1,477 - $1,876
15 New
15 $1,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $24.2B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Nbc Securities, Inc. Portfolio

Follow Nbc Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nbc Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nbc Securities, Inc. with notifications on news.